B.M.P. PHARMA TRAD (BMP.SG) (BMP) - Net Assets
Based on the latest financial reports, B.M.P. PHARMA TRAD (BMP.SG) (BMP) has net assets worth €8.94 Million EUR (≈ $10.45 Million USD) as of December 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€13.43 Million ≈ $15.70 Million USD) and total liabilities (€4.49 Million ≈ $5.25 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read B.M.P. PHARMA TRAD (BMP.SG) (BMP) financial obligations for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €8.94 Million |
| % of Total Assets | 66.53% |
| Annual Growth Rate | 5.97% |
| 5-Year Change | 46.56% |
| 10-Year Change | 73.61% |
| Growth Volatility | 13.29 |
B.M.P. PHARMA TRAD (BMP.SG) - Net Assets Trend (2013–2024)
This chart illustrates how B.M.P. PHARMA TRAD (BMP.SG)'s net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of B.M.P. PHARMA TRAD (BMP.SG) for the complete picture of this company's asset base.
Annual Net Assets for B.M.P. PHARMA TRAD (BMP.SG) (2013–2024)
The table below shows the annual net assets of B.M.P. PHARMA TRAD (BMP.SG) from 2013 to 2024. For live valuation and market cap data, see B.M.P. PHARMA TRAD (BMP.SG) (BMP) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €8.94 Million ≈ $10.45 Million |
+2.93% |
| 2023-12-31 | €8.68 Million ≈ $10.15 Million |
-14.73% |
| 2022-12-31 | €10.18 Million ≈ $11.90 Million |
+18.23% |
| 2021-12-31 | €8.61 Million ≈ $10.07 Million |
+41.23% |
| 2020-12-31 | €6.10 Million ≈ $7.13 Million |
+2.86% |
| 2019-12-31 | €5.93 Million ≈ $6.93 Million |
+5.51% |
| 2018-12-31 | €5.62 Million ≈ $6.57 Million |
+8.92% |
| 2017-12-31 | €5.16 Million ≈ $6.03 Million |
+0.32% |
| 2016-12-31 | €5.14 Million ≈ $6.01 Million |
-0.11% |
| 2015-12-31 | €5.15 Million ≈ $6.02 Million |
+8.08% |
| 2014-12-31 | €4.76 Million ≈ $5.57 Million |
+0.87% |
| 2013-12-31 | €4.72 Million ≈ $5.52 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to B.M.P. PHARMA TRAD (BMP.SG)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 406676443.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €3.08 Million | 34.52% |
| Other Components | €5.85 Million | 65.48% |
| Total Equity | €8.94 Million | 100.00% |
B.M.P. PHARMA TRAD (BMP.SG) Competitors by Market Cap
The table below lists competitors of B.M.P. PHARMA TRAD (BMP.SG) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Adval Tech Holding AG
SW:ADVN
|
$26.28 Million |
|
Veea Inc.
NASDAQ:VEEA
|
$26.31 Million |
|
Greencoat UK Wind PLC
LSE:UKW
|
$26.31 Million |
|
Sumit Woods Limited
NSE:SUMIT
|
$26.32 Million |
|
BioXcel Therapeutics Inc
NASDAQ:BTAI
|
$26.24 Million |
|
ED Invest S.A.
WAR:EDI
|
$26.23 Million |
|
Santierul Naval Orsova SA
RO:SNO
|
$26.23 Million |
|
Thai Film Industries Public Company Limited
BK:TFI
|
$26.22 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in B.M.P. PHARMA TRAD (BMP.SG)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,681,305 to 8,935,863, a change of 254,558 (2.9%).
- Net income of 2,879,558 contributed positively to equity growth.
- Other factors decreased equity by 2,625,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €2.88 Million | +32.22% |
| Other Changes | €-2.63 Million | -29.38% |
| Total Change | €- | 2.93% |
Book Value vs Market Value Analysis
This analysis compares B.M.P. PHARMA TRAD (BMP.SG)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.94x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.09x to 2.94x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €0.98 | €5.00 | x |
| 2018-12-31 | €1.07 | €5.00 | x |
| 2019-12-31 | €1.13 | €5.00 | x |
| 2020-12-31 | €1.16 | €5.00 | x |
| 2021-12-31 | €1.64 | €5.00 | x |
| 2022-12-31 | €1.94 | €5.00 | x |
| 2023-12-31 | €1.65 | €5.00 | x |
| 2024-12-31 | €1.70 | €5.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently B.M.P. PHARMA TRAD (BMP.SG) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 32.22%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 179439.64%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.50x
- Recent ROE (32.22%) is above the historical average (11.78%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 6.80% | 10700.00% | 0.00x | 1.04x | €-151.10K |
| 2014 | 0.86% | 4100.00% | 0.00x | 1.03x | €-435.20K |
| 2015 | 7.48% | 3850.00% | 0.00x | 1.05x | €-129.70K |
| 2016 | -0.12% | -144.60% | 0.00x | 1.06x | €-520.21K |
| 2017 | 0.32% | 937.82% | 0.00x | 1.08x | €-499.37K |
| 2018 | 8.19% | 6404.23% | 0.00x | 1.07x | €-101.51K |
| 2019 | 5.22% | 27763.22% | 0.00x | 1.08x | €-283.39K |
| 2020 | 2.79% | 17000.00% | 0.00x | 1.14x | €-439.70K |
| 2021 | 30.41% | 58819.09% | 0.00x | 1.14x | €1.76 Million |
| 2022 | 15.42% | 95665.46% | 0.00x | 1.21x | €551.61K |
| 2023 | 31.71% | 4894360.07% | 0.00x | 1.40x | €1.88 Million |
| 2024 | 32.22% | 179439.64% | 0.00x | 1.50x | €1.99 Million |
Industry Comparison
This section compares B.M.P. PHARMA TRAD (BMP.SG)'s net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $94,283,452,554
- Average return on equity (ROE) among peers: -1.70%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| B.M.P. PHARMA TRAD (BMP.SG) (BMP) | €8.94 Million | 6.80% | 0.50x | $26.25 Million |
| AMUR MINERALS (A7L.SG) (A7L) | $31.35 Million | -8.51% | 0.03x | $25.37K |
| Novae Group Plc (NVAL) | $376.37 Billion | 5.47% | 0.67x | $47.53K |
| OPG POWER VENTURES (OPB.SG) (OPB) | $154.38 Million | 9.08% | 1.23x | $13.57 Million |
| SY PUBLIC UTIL -H- (SH3.SG) (SH3) | $573.35 Million | -12.82% | 0.31x | $353.87K |
About B.M.P. PHARMA TRAD (BMP.SG)
There is no Profile data available for BMP.SG.